Atrial fibrillation and rheumatic valvular heart disease:usefulness of very-low-dose amiodarone

作     者：Tsuyoshi Shiga 

作者机构：Department of CardiologyTokyo Women's Medical University8-1 Kawada-choShinjuku-kuTokyo 162-8666Japan 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2006年第119卷第24期

页      面：2027-2029页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：Department of Cardiology Tokyo Women's Medical University 8-1 Kawada-cho Shinjuku-ku Tokyo(162-8666) 

主　　题：Atrial fibrillation and rheumatic valvular heart disease very 

摘      要：Atrial fibrillation （AF） is frequently associated with rheumatic valvular heart disease （RVHD）. AF leads to systemic thromboembolic complications, reduced quality of life （QOL）, impaired ventricular function and also increased mortality. Multivariate analysis of results from a population-based study has shown that valvular heart disease is one of risk factors for development of AF.1 The frequency of RVHD has decreased in developed countries in recent years, but RVHD now constitutes a significant population for the cardiology services in developing countries.